NCT01934673
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Selangor Darul Ehsan, Malaysia
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
7,983 public trials
714 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT02305355
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Bucheon St. Mary's Hospital Bucheon-si, South Korea
Completed
Study to Compare 2 Doses of Polycap Versus Single Dose of Polycap With or Without Pottasium
NCT01404078
- Conditions
- Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +17 more
- Locations
-
Not specified
NCT00686634
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Charles Drew University of Medicine and Science Los Angeles, California, United States
Completed
Exogenous Glucose Oxidation Breath Test
NCT01846767
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Physiology laboratory Galway, Ireland
Completed
4 Weeks Treatment With Empagliflozin (BI 10773) in Japanese Type 2 Diabetic Patients (T2DM)
NCT00885118
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- 1245.15.003 Boehringer Ingelheim Investigational Site Hachioji, Tokyo, Japan
- 1245.15.002 Boehringer Ingelheim Investigational Site Koganei, Tokyo, Japan
- 1245.15.001 Boehringer Ingelheim Investigational Site Nakano-ku, Tokyo, Japan
- 1245.15.005 Boehringer Ingelheim Investigational Site Suita, Osaka, Japan
NCT01438814
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- 1218.60.90001 Boehringer Ingelheim Investigational Site Dhaka, Bangladesh
- 1218.60.90002 Boehringer Ingelheim Investigational Site Dhaka, Bangladesh
- 1218.60.90003 Boehringer Ingelheim Investigational Site Dhaka, Bangladesh
- 1218.60.32001 Boehringer Ingelheim Investigational Site Genk, Belgium
Completed
Randomized, Placebo-controlled, 2 Period, Single-blind, Sequential, Multiple Ascending Dose Study
NCT01956305
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Worldwide Clinical Trials San Antonio, Texas, United States
Completed
Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 Diabetes
NCT00274274
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Düsseldorf, Germany
Completed
Effects of Pioglitazone on High-density Lipoprotein (HDL) Function in Persons With Diabetes
NCT01156597
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemias, +6 more
- Locations
-
- Diabetes Research Institute Miami, Florida, United States